Search

Katrine Whiteson (University of California, Irvine) has been awarded a Pilot Program grant for phage therapy research by the Susan Samueli Integrative Health Institute to develop and refine phage therapy protocols for treating antibiotic-re

The (NIH Division of Microbiology and Infectious Diseases) recently discussed a new suggested funding solicitation for phage therapy centers — here’s the recording of the council meeting!

Dr Ameneh Khatami (University of Sydney, Phage Australia) has been awarded $4.3 million to investigate the use of a locally produced two-phage combination that targets S. aureus to see if it provides an advantage in addition to antibiotics

Oxford Silk Phage Technology, in collaboration with the University of Exeter and the University of Hertfordshire, has been awarded 2 million British pounds via a new Collaborative Innovate UK Biomedical Catalyst grant. The funds will accele

Andrea Fossati just announced that their grant for investigating phage-Mycobacterium tuberculosis interactions was funded by Vetenskapsradet (the Swedish Research Council).

Professor Martha Clokie and Dr Anisha Thanki have been awarded £800,000 from the UK BBSRC to advance the production of safe and effective phages for combating disease in the veterinary field, with the aim of bringing them to market in accor

Heather Hendrickson and Peter Fineran have had a major new phage project funded: ~9 million to set up a phage pipeline to protect primary industries in New Zealand, such as kiwifruit and apiculture sectors. Their programme aims to create a

Intralytix has received an SBIR Phase III grant from the U.S. Department of Agriculture to optimize SalmoFresh™ application for small and medium poultry and meat producers.

Researchers from UC San Diego, the J. Craig Venter Institute and Yale University have been awarded $10 million by the Howard Hughes Medical Institute (HHMI) to support research on using jumbo viruses as new therapeutic agents.

Emily’s Entourage, a nonprofit foundation that accelerates research for new treatments and a cure for the final 10% of people with cystic fibrosis, including those with nonsense mutations, announced it has awarded $220,000 in funding to Gra

I'm very happy to share that our new project entitled "SUPPLY: SUperfast Photonic detection of Phage LYsis" has been granted ~1.3 Millions by the FNS-ANR in the last Lead Agency call. I'm very excited to start this four-year collaboration w

Felix Biotechnology has been awarded a Small Business Innovation Research (SBIR) Phase I grant for $314,411 from the National Institute of Health (NIH) to develop a microfluidics platform for rapid, high-throughput screening of therapeutic

The CF Foundation has awarded $5 Million to BiomX to conduct a Phase 1b/2a clinical trial to test the safety and tolerability of phage therapy for Pseudomonas aeruginosa infections in people with cystic fibrosis.

JPIAMR (Joint Programming Initiative on Antimicrobial Resistance) has awarded funding to multiple new phage-related projects in the One Health space! Funded phage projects include: - Use of phage applications to combat MRSA at the sow-pigle

US phage biotech company Intralytix received a Fast Track NIH SBIR contract to develop a universal, scale-independent AI-based platform for manufacturing high titer phage preparations for clinical applications. Intralytix will receive a Pha

The NSW Government, Australian Federal Government and industry partners have committed $3 Million to launch “Phage Australia”. The project, led by Prof. Jonathan Iredell at the Westmead Institute for Medical Research, along with colleagues

NIAID has awarded $2.5 million in grants to 12 institutes around the world to support research on phage therapy! These awards represent NIAID’s first series of grants focused exclusively on research on phage therapy. Congrats to all recipie

PhagePro Inc., a Boston-based phage biotech company, is pleased to announce that it recently received a total of $3 million under an NIH Phase II Small Business Innovation Research (SBIR) grant and an NIH Exploratory/Developmental Research

BCM TAILΦR Labs (Tailored Antibacterials and Innovative Laboratories for phage (Φ) Research) and a team of their collaborators was awarded a 7.5 million dollar U19 grant by the National Institute of Allergy and Infectious Diseases. Congrats

Emily’s Entourage, a nonprofit organization that funds cystic fibrosis research and drug development, has funded four new grants (totaling $790,000 over two years), two of which are phage-related. One was awarded to IPATH researchers to dev